ResMed Reports Fiscal Q3 2026 Revenue of $1.41B, EPS of $2.92
ResMed reported revenue of $1.41 billion, up 5.9% year over year. Net income rose 20% to $418.41 million and diluted EPS increased 23.2% to $2.92.
ResMed reported third-quarter fiscal 2026 revenue of $1.41 billion, up 5.9% from the prior-year quarter, while net income rose 20% to $418.41 million and diluted EPS increased 23.2% to $2.92.Financial Highlights¹ Reported as “Net revenue”. ² Reported as “Net income”. ³ Reported as “Diluted earnings…